Cost-utility analysis of biologic disease-modifying antirheumatic drugs (bDMARDs), targeted synthetic DMARDs (tsDMARDs) and biosimilar DMARDs (bsDMARDs) combined with methotrexate for Thai rheumatoid arthritis patients with high disease activity
对泰国高疾病活动度类风湿关节炎患者，采用生物制剂类疾病修饰抗风湿药（bDMARDs）、靶向合成DMARDs（tsDMARDs）和生物类似药DMARDs（bsDMARDs）联合甲氨蝶呤治疗的成本效益分析
期刊:BMC Health Services Research
影响因子:
doi:10.1186/s12913-023-09595-1
Prawjaeng, Juthamas; Leelahavarong, Pattara; Budtarad, Nuttakarn; Pilasant, Songyot; Chanjam, Chonticha; Katchamart, Wanruchada; Narongroeknawin, Pongthorn; Kitumnuaypong, Tasanee
